BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 26, 2015
View Archived Issues
Safety and toxicity results presented for pralatrexate plus oxaliplatin combination treatment
Read More
Cabozantinib S-malate shows limited activity in advanced CCA patients
Read More
Combination of pimasertib and gemcitabine fails to improve PFS
Read More
PF-04136309 and FOLFIRINOX shows no additional toxicity in pancreatic adenocarcinoma
Read More
Selective cannabinoid CB1 receptor antagonism improves diabetic nephropathy
Read More
Jakavi recommended for approval in Europe for polycythemia vera
Read More
Senshio approved in Europe for vulvar and vaginal atrophy
Read More
Data and safety monitoring board recommends continuation of phase II masitinib
Read More
ISIS-416858 shows potential to decrease postoperative thrombosis
Read More
Researchers at BMS disclose new ROCK-2 inhibitors
Read More
Calibr patents novel dimeric compounds for COPD and cystic fibrosis
Read More
Millennium Pharmaceuticals reports SUMO-activating enzyme inhibitors
Read More
New cyclin-G-associated kinase ligands designed at KU Leuven
Read More
ZIOPHARM Oncology presents ongoing projects
Read More
Scientists in Japan prepare and test novel P2X4 antagonists for pain
Read More
Merck & Co. completes Cubist tender offer
Read More
Array BioPharma to acquire worldwide rights to encorafenib
Read More
EMA committee recommends approval of Saxenda for weight management
Read More
EMA recommends approval of Abraxane for NSCLC
Read More
FDA accepts Praluent BLA for priority review
Read More
European CHMP recommends new approval of Eylea
Read More
Neomed receives approval to begin phase I trial of NEO-6860
Read More
Galapagos receives grant for antibiotic research
Read More
FDA approves Bexsero meningitis B vaccine
Read More
The Medicines Company receives CHMP recommendations for three acute care products
Read More
FDA grants fast track designation to intrathecally idursulfase
Read More
Cubist's tedizolid phosphate recommended for approval in E.U. for ABSSSI
Read More